04.24.2018 Issue 399

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Round-up
The Top Story in HEOR: Latest Headlines in HEOR:

Employers Taking Aim at Drug Prices

Monday, April 23

Employers during the National Business Group on Health’s conference made clear their frustrations about the U.S. health care system, namely drug pricing.

Scale of Errors in Clinical Trial Registries Shocks Researchers

Article: Market Access Operates Differently for Medical Devices than for Pharmaceuticals

Where Does Innovation Rank in Value Frameworks?

Q&A With Lou Garrison on RWE, HTA

23andMe Gets OK from FDA to Report Breast Cancer Risk

2017 Drug Spending Grows Less than 1%

Epidemiologic Reviews Issues Call for Papers

Biosimilars: US Payer Perspectives

Khullar: How Doctors Can Help Patients Assess Risk

A Glimpse at Uwe Reinhardt’s Memorial Service

Junior Health Economist

Health Economics & Market Access (Senior) Consultant

Senior Compliance Manager

Assistant/Associate Director GHEOR (Remote Position)

Analyst/Manager GHEOR (Remote Position)

Manager, Analytics, RWE Design and Analytics (1 of 2)

Senior Medical Writer - Medical Writing & Healthcare Communications - London or Remote

Industry Spotlight

Conferences Webinars

4th Annual Endpoint Adjudication
    May 1-2, Philadelphia, PA

BioBasics: Biotech the Non-scientist
    May 2-3, San Diego, CA

HLTH: THe Future of Health Care
    May 6-9, Las Vegas, NV

2nd Annual Drug Pricing Transparency Congress
    May 10, Philadelphia, PA

7th Annual Conference on Healthcare Markets
    May 11, Evanston, IL

Innovating with Standardization to Scale VBP Programs
    April 24

Globalization Consulting: Smart Information Products for Global Audiences
    April 25

Data Anonymization for Statisticians
    April 26

The Flu in Review: What Big Data Can Teach Us
    April 26

Exclusive Insights into HEOR and Market Access Salary Survey
    May 9

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
KAM Metrics: Driving Efficiency, Measuring Success

Biosimilars: E.U. Payer Perspectives

MSL Teams: Field Force Size and Structure

Market Access Impact: Type 2 Diabetes Mellitus (Injectables) (US) 2017

Market Access Impact: Type 2 Diabetes Mellitus (Orals) (US) 2017

Market Access Impact: Rheumatoid Arthritis (US) 2017

A Framework to Guide the Optimal Development and Use of Real World Evidence for Coverage and Formulary Decisions

Improve Quality Measures with mPulse Mobile Solutions

Real World Evidence for Coverage Decisions: Opportunities and Challenges

Blockchain-enabled Genomic Data Sharing and Analysis Platform

Reforming Biopharmaceutical Pricing at Home and Abroad

Special Thanks to Our Partners:
   Evidera    G&J Lee RecruitmentHealthCoreMAPSUniversity of FL
              Truven    XcendaOM1Parexel   Jefferson
      Dymaxium    Curo    Precision XtractPharmeritDRG Abacus
eMax HealthSciformixEvidence PartnersICON